Henriksen, Ben Tore http://orcid.org/0000-0001-7250-7597
Krogseth, Maria http://orcid.org/0000-0002-6121-9044
Andersen, Randi Dovland http://orcid.org/0000-0001-6857-7058
Davies, Maren Nordsveen
Nguyen, Caroline Thy
Mathiesen, Liv http://orcid.org/0000-0002-6598-2215
Andersson, Yvonne http://orcid.org/0000-0003-3528-7171
Clinical trials referenced in this document:
Documents that mention this clinical trial
Clinical pharmacist intervention to improve medication safety for hip fracture patients through secondary and primary care settings: a nonrandomised controlled trial
https://doi.org/10.1186/s13018-023-03906-2
Funding for this research was provided by:
Vestfold Hospital Trust, Norway
Hospital Pharmacies Enterprise, South Eastern Norway, Norway
Article History
Received: 4 February 2023
Accepted: 4 June 2023
First Online: 13 June 2023
Declarations
:
: The Regional Committee for Medical and Health Research Ethics in South East Norway found the study to be outside the Norwegian Health Research Act (ref ID: 2017/2172, 20 December 2017). In accordance with Norwegian law, the study was approved by Norwegian Centre for Research Data (ref ID: 556662 and 359479), the Data Protection Official for Vestfold Hospital Trust at the time the study was conducted. This study was performed in line with the principles of the Declaration of Helsinki.
: All patients, or their next-of-kin, in the intervention group gave their informed and written consent, in accordance with approval. The control patients were exempted consent in accordance with approval.
: Not applicable.
: Ben Tore Henriksen, Maria Krogseth, Randi Dovland Andersen, Maren Nordsveen Davies, Caroline Thy Nguyen, Liv Mathiesen, and Yvonne Andersson report no competing interests.